Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 15, 2019 Filed Aug 16, 2019 14:59 UTC
Young James MCorporate VP and CFO
Exercise / conversionStock Option (Right to Buy) · Derivative 28,437 $0.00 Strike: $50.95 $0.00
Disclosure

SEC source: 0001225208-19-011470 · doc4.xml · derivative · entry 4

Young James M · CIK 0001610934 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,959

Underlying: Common Stock · 28,437 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 30, 2019.

Read SEC document
August 15, 2019 Filed Aug 16, 2019 14:59 UTC
Young James MCorporate VP and CFO
SaleCommon Stock 24,166 $126.45 $3,055,897.03
Disclosure

SEC source: 0001225208-19-011470 · doc4.xml · nonDerivative · entry 3

Young James M · CIK 0001610934 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,984

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 30, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.74 - $126.96, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Read SEC document
August 15, 2019 Filed Aug 16, 2019 14:59 UTC
Young James MCorporate VP and CFO
SaleCommon Stock 14,000 $126.45 $1,770,343.40
Disclosure

SEC source: 0001225208-19-011470 · doc4.xml · nonDerivative · entry 2

Young James M · CIK 0001610934 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,150

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 30, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.74 - $126.92, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
August 15, 2019 Filed Aug 16, 2019 14:59 UTC
Young James MCorporate VP and CFO
Exercise / conversionCommon Stock 28,437 $50.95 $1,448,865.15
Disclosure

SEC source: 0001225208-19-011470 · doc4.xml · nonDerivative · entry 1

Young James M · CIK 0001610934 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 30, 2019.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 11:13 UTC
Matlin LauraVP, Deputy GC and CGO
GrantCommon Stock 1,378 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010946 · doc4.xml · nonDerivative · entry 1

Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,365.696

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 11:13 UTC
Mayadas VijayCorporate Vice President
GrantCommon Stock 1,773 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010947 · doc4.xml · nonDerivative · entry 1

Mayadas Vijay · CIK 0001658677 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,285.756

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 11:13 UTC
Liberatore MichaelVP, ICS - Mutual Funds
GrantCommon Stock 2,562 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010945 · doc4.xml · nonDerivative · entry 1

Liberatore Michael · CIK 0001659018 · VP, ICS - Mutual Funds

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,116.91

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
Gokey Timothy CPresident and CEO
GrantCommon Stock 15,375 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010943 · doc4.xml · nonDerivative · entry 1

Gokey Timothy C · CIK 0001296187 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,849.0271

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
Carey Thomas PCorporate VP
GrantCommon Stock 1,261 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010940 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,248

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 6, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 11:13 UTC
DALY RICHARD JDirector · Executive Chairman
GrantCommon Stock 47,311 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010941 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,922.0229

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
Young James MCorporate VP and CFO
GrantCommon Stock 13,010 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010952 · doc4.xml · nonDerivative · entry 1

Young James M · CIK 0001610934 · Corporate VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,713

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
Taylor Julie R.Corporate VP and CHRO
GrantCommon Stock 3,942 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010951 · doc4.xml · nonDerivative · entry 1

Taylor Julie R. · CIK 0001588233 · Corporate VP and CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,281.327

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
Tae Michael SCorporate VP, Corp. Strategy
GrantCommon Stock 2,758 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010950 · doc4.xml · nonDerivative · entry 1

Tae Michael S · CIK 0001663476 · Corporate VP, Corp. Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,758

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
SCHIFELLITE ROBERTCorporate SVP
GrantCommon Stock 7,885 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010949 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,302.6729

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC GrantCommon Stock 5,518 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010948 · doc4.xml · nonDerivative · entry 1

PERRY CHRISTOPHER JOHN · CIK 0001619128 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,005.528

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
KALENKA ROBERT FCorporate Vice President
GrantCommon Stock 2,758 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010944 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,744.4097

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
GrantCommon Stock 2,758 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010942 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,840.8948

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
August 06, 2019 Filed Aug 7, 2019 15:13 UTC
AMSTERDAM ADAM DCorporate Vice President
GrantCommon Stock 5,518 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010939 · doc4.xml · nonDerivative · entry 1

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,137.3989

F1 · date: The reported transaction reflects the amount of Restricted Stock Units granted under Broadridge's 2018 Omnibus Award Plan as determined at the end of a two-year performance period and represent a like number of shares of Broadridge common stock. The Restricted Stock Units will vest and convert into shares of Broadridge common stock on April 1, 2020.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 14:41 UTC GrantCommon Stock 56 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010083 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,312

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 10:41 UTC GrantCommon Stock 56 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010087 · doc4.xml · nonDerivative · entry 1

PERNA THOMAS J · CIK 0001209487 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,312

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 10:41 UTC GrantCommon Stock 56 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010085 · doc4.xml · nonDerivative · entry 1

Levine Stuart R · CIK 0001186624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,045

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 10:41 UTC
WEBER ALAN JDirector
GrantCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010088 · doc4.xml · nonDerivative · entry 2

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,270

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 10:41 UTC
WEBER ALAN JDirector
GrantCommon Stock 56 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010088 · doc4.xml · nonDerivative · entry 1

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,269

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 14:41 UTC
keller brettDirector
GrantCommon Stock 16 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010084 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,453

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 10:41 UTC GrantCommon Stock 81 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010081 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,182

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 14:41 UTC GrantCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010086 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,855

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

F2 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 14:41 UTC GrantCommon Stock 34 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010086 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,854

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
July 03, 2019 Filed Jul 8, 2019 14:41 UTC GrantCommon Stock 5 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-010082 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,521

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

F1 · price: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
June 24, 2019 Filed Jun 25, 2019 11:48 UTC
DALY RICHARD JDirector · Executive Chairman
SaleCommon Stock 7,500 $128.93 $966,959.25
Disclosure

SEC source: 0001225208-19-009527 · doc4.xml · nonDerivative · entry 1

DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · by The KLD 2014 Trust

Disclosed balance after: 1,985

F1 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person, The KLD 2014 Trust adopted on May 21, 2019.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.09 - $129.55, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 4,178 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · derivative · entry 13

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,536

Underlying: Common Stock · 4,178 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 5,400 $0.00 Strike: $67.32 $0.00
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · derivative · entry 12

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,799

Underlying: Common Stock · 5,400 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 5,556 $0.00 Strike: $50.95 $0.00
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · derivative · entry 11

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,556 shares

Expires 2025-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 6,573 $0.00 Strike: $51.95 $0.00
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · derivative · entry 10

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,573

Underlying: Common Stock · 6,573 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
SaleCommon Stock 5,567 $128.92 $717,703.21
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 9

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,619.3989

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.08 - $129.62, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (7) to this Form 4.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
SaleCommon Stock 4,736 $128.91 $610,528.65
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 8

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,186.3989

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.07 - $129.62, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (6) to this Form 4.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
SaleCommon Stock 4,695 $128.92 $605,287.85
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 7

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,922.3989

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.92 - $129.62, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
SaleCommon Stock 3,882 $128.92 $500,449.97
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 6

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,617.3989

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.07 - $129.61, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
SaleCommon Stock 2,000 $128.98 $257,959.80
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 5

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,499.3989

F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.58 - $129.48, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionCommon Stock 4,178 $93.88 $392,230.64
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 4

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,499.3989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionCommon Stock 5,400 $67.32 $363,528.00
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 3

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,321.3989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionCommon Stock 5,556 $50.95 $283,078.20
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 2

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,921.3989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 24, 2019 Filed Jun 26, 2019 15:22 UTC
AMSTERDAM ADAM DCorporate Vice President
Exercise / conversionCommon Stock 6,573 $51.95 $341,467.35
Disclosure

SEC source: 0001225208-19-009559 · doc4.xml · nonDerivative · entry 1

AMSTERDAM ADAM D · CIK 0001391094 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,365.3989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on May 22, 2019.

Read SEC document
June 17, 2019 Filed Jun 18, 2019 14:14 UTC
WEBER ALAN JDirector
GrantCommon Stock 249 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009357 · doc4.xml · nonDerivative · entry 1

WEBER ALAN J · CIK 0001198093 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,213

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 17, 2019 Filed Jun 18, 2019 18:14 UTC GrantCommon Stock 220 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009356 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,820

F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
June 10, 2019 Filed Jun 11, 2019 17:57 UTC
KALENKA ROBERT FCorporate Vice President
SaleCommon Stock 8,000 $132.58 $1,060,643.20
Disclosure

SEC source: 0001225208-19-009095 · doc4.xml · nonDerivative · entry 1

KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,986.4097

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.5703 - $132.6300, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each.

Read SEC document
May 31, 2019 Filed Jun 3, 2019 15:58 UTC
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
SaleCommon Stock 16,200 $124.91 $2,023,511.22
Disclosure

SEC source: 0001225208-19-008688 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,082.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.67 - $125.17, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 28, 2019 Filed May 29, 2019 15:10 UTC
SCHIFELLITE ROBERTCorporate SVP
SaleCommon Stock 15,000 $125.01 $1,875,186.00
Disclosure

SEC source: 0001225208-19-008592 · doc4.xml · nonDerivative · entry 1

SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,417.6729

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.86 - $125.14, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 24, 2019 Filed May 28, 2019 14:24 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 12,074 $0.00 Strike: $22.67 $0.00
Disclosure

SEC source: 0001225208-19-008551 · doc4.xml · derivative · entry 9

Levine Stuart R · CIK 0001186624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,074 shares

Expires 2022-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2019 Filed May 28, 2019 14:24 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,869 $0.00 Strike: $22.90 $0.00
Disclosure

SEC source: 0001225208-19-008551 · doc4.xml · derivative · entry 8

Levine Stuart R · CIK 0001186624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,869 shares

Expires 2021-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2019 Filed May 28, 2019 14:24 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 15,100 $0.00 Strike: $21.94 $0.00
Disclosure

SEC source: 0001225208-19-008551 · doc4.xml · derivative · entry 7

Levine Stuart R · CIK 0001186624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,100 shares

Expires 2020-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.